Ribavirin Capsule
Product Images NDC 65862-290

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Ribavirin (NDC 65862-290). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Aurobindo Pharma Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Package Label-principal Display Panel (200 mg (500 Capsules Bottle))

Package Label-principal Display Panel (200 mg (500 Capsules Bottle))
This text is a pharmaceutical label for Ribavirin capsules USP manufactured by Aurobindo Pharma USA, Inc. It contains instructions for dispensing and storing the medication as well as warnings about pregnancy and combination use with INTRONCA Injection. The dosage instructions and the medication guide should be carefully read before use. The capsules are only available with a prescription.*
FDA Label Image

Chemical Structure (Ribavirin Str)

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.